Another memorable Gather Round is in the books. There were several impressive performances across the board — including three ...

Pfizer (PFE) announced early Monday that it is halting a late-stage trial of its GLP-1 pill candidate, danuglipron, dashing hopes of the company entering the obesity space in the near term.

Shares of Lupin and Zydus Life are sharply lower by 3-4.5 percent on April 16 after losing a US Federal Court patent case involving Myrbetriq - a prescription medicine used in treating overactive ...

Matthew Herper covers medical innovation — both its promise and its perils. Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron ...

A daily weight loss pill that works like breakthrough fat jab ... It works by targeting the same GLP-1 receptors as Blockbuster weight-loss jabs Ozempic, Wegovy and Mounjaro, which suppress ...

From STAT’s Matthew Herper: Pfizer said this morning that it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity, focusing its efforts on another ...

Millions of us rely on a cup of coffee for an energy hit first thing in the morning. But experts say enjoying the drink at this time of the day could come with unfortunate health risks. The ...

This week's £10 Tuesday Boots sale includes a supplement that's 'clinically proven to lower cholesterol levels'. The retailer's weekly shopping event sees hundreds of products discounted.

Or try different combinations with characters that look alike, such as “1,” “I” (uppercase i), and “l” (lower case L). Always compare the pill in hand with the image in the Pill ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...